AEON Insider Trading

Insider Ownership Percentage: 20.00%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $73,803,940.00

AEON Biopharma Insider Trading History Chart

This chart shows the insider buying and selling history at AEON Biopharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

AEON Biopharma Share Price & Price History

Current Price: $2.56
Price Change: Price Decrease of -0.08 (-3.03%)
As of 07/18/2024 01:00 AM ET

This chart shows the closing price history over time for AEON up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

AEON Biopharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/11/2023Crown Holdings Grou StrathspeyMajor ShareholderSell7,380,394$10.00$73,803,940.002,031,773View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for AEON Biopharma (NASDAQ:AEON)

22.78% of AEON Biopharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at AEON by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

AEON Biopharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/17/2024Shaolin Capital Management LLC21,380$0.25M0.0%-97.7%0.057%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.758,992$8.80M0.0%+261.8%2.008%Search for SEC Filing on Google Icon
2/7/2024Formidable Asset Management LLC58,193$0.42M0.1%-9.5%0.157%Search for SEC Filing on Google Icon
11/9/2023Formidable Asset Management LLC64,311$0.36M0.1%N/A0.723%Search for SEC Filing on Google Icon
11/6/2023Atalaya Capital Management LP3,675,000$19.83M21.7%N/A41.283%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
AEON Biopharma logo
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine. AEON Biopharma, Inc. is based in Irvine, California.
Read More on AEON Biopharma

Today's Range

Now: $2.56
Low: $2.51
High: $2.90

50 Day Range

MA: $1.48
Low: $0.96
High: $2.88

52 Week Range

Now: $2.56
Low: $0.92
High: $17.17

Volume

1,023,475 shs

Average Volume

4,888,351 shs

Market Capitalization

$100.15 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.4

Who are the company insiders with the largest holdings of AEON Biopharma?

AEON Biopharma's top insider shareholders include:
  1. Crown Holdings Grou Strathspey (Major Shareholder)
Learn More about top insider investors at AEON Biopharma.